A 10-year retrospective study of inpatient adolescents with schizophrenia/schizoaffective disorder and substance use
Introduction
The comorbidity of schizophrenia and substance abuse is well documented, with up to 60% of the patients being reported using or abusing illicit drugs [1], [2], [3], [4]. The rates in inpatient settings are in the same range and are sometimes even higher [4], [5], [6], [7], [8].
Substance abuse among patients with schizophrenia is considered a major clinical and public health concern [9]. Apart from tobacco consumption (over 70%), the most frequently used substances are alcohol (37%), cannabis (23%), and stimulants or hallucinogens (13%) [10], [11], [12], [13]. The abuse of most of these substances has been linked to psychotic symptom exacerbation, repeated hospitalizations, poor social functioning, homelessness, increased suicide risk, and poor response to treatment [5], [14], [15], [16].
To better understand the relationship between schizophrenia and the use and abuse of substances at rates far exceeding those found in the unaffected population, several models have been proposed [9], [17], [18], [19], [20]. The etiological model hypothesizes that drug abuse is a causative factor in the development of this disease in a subgroup of patients with schizophrenia [21], [22], [23], [24]. Alternatively, the dopamine model suggests that disturbances in the reinforcement and reward function of the dopamine-producing areas of the brain may increase the vulnerability to both schizophrenia and drug abuse in some patients [25]. A third model, the socializing effects paradigm, considers drug use by patients with schizophrenia to be interpersonally reinforcing as it renders handicapped and isolated patients' social identity and group [26]. Finally, the self-medication model suggests that patients suffering from schizophrenia may use drugs to ameliorate depression [27], negative symptoms [28], or neuroleptic-induced extrapyramidal side effects [29].
A prospective study in adults has found that substance abuse in patients with schizophrenia is associated with suicidality and impulsivity, but the data collected revealed no correlation with scores on the Chapman Physical Anhedonia Scale, the Positive and Negative Syndrome Scale, the Clinical Global Improvement scores, or with treatment response and demographic variables [30]. Another recent study found that schizophrenic patients with substance use were younger, more likely to be male, had a shorter duration of illness, and had more police contact, but symptoms, service use, or social functioning were only minimally affected [31]. A schizophrenic patient's history of substance use was shown to be among the predicting factors of aggression during hospitalization [32] and has been reported to be associated with an earlier age of onset of the psychotic disorder [33], [34]. Finally, a longitudinal study of adult schizophrenia and schizoaffective inpatients found that substance abuse among this group was correlated with fewer negative and positive symptoms, better sexual adjustment, worse school performance during adolescence, and greater family histories of drug abuse [5]. Cannabis, alcohol, and cocaine were the most commonly used drugs in that cohort. The authors concluded that patients with schizophrenia who abuse drugs may represent a subgroup with a different prognosis.
To the best of our knowledge, similar studies have not been performed in adolescents. The developmental phase of adolescence is regarded as a time of vulnerability to the adverse effects of misused substances upon psychological functioning [35]. Drugs and alcohol may interfere with learning, social and personal development, may aggravate preexisting emotional distress, and may lead to a progression to the use of other substances, possibly in increased doses. These implications may well be more severe in adolescent patients with schizophrenia.
A review of the literature regarding suicidality and substance abuse indicates that drug and alcohol use was found to be associated with suicidal behavior not only in adults [36], [37] but also in adolescents as well [38], [39], [40], [41]. Schizophrenia by itself is associated with an increased rate of suicidality; thus, substance use in these patients is expected to further increase the risk of potentially lethal self-injurious behavior. We have been unable to find a comprehensive study on the effect of substance use on suicidal behavior among adolescent inpatients with schizophrenia.
The issue of the underrecognition of substance use and abuse by medical staff has been dealt with previously [42], [43]. For example, it has been noted recently that although substance misuse is very common in psychiatric patients [3], most patients were not questioned about such behavior by admitting psychiatrists [44]. General physicians were reported long ago to be poor at taking substance use and abuse histories and alcohol history in many clinical settings [45]. This finding emphasizes the importance of obtaining more data on the clinical features of substance-using and substance-misusing adolescent patients.
We performed a retrospective study of inpatient adolescents with schizophrenia and schizoaffective disorder. The goal of this study was to identify the clinical correlates and to characterize adolescent psychotic inpatients with and without comorbid substance use.
Section snippets
Subjects
The sample consisted of 188 adolescents diagnosed with either schizophrenia or schizoaffective disorder. All patients admitted to the adolescent inpatient unit at a university-affiliated mental health center in Israel between the years 1994 and 2004 were included unless the duration of their hospitalization was less than 5 days. The reason for this exclusion was a dearth of clinical and anamnesis data on these patients. During this 10-year period, there were no changes in the hospital's review
Results
Of the 188 adolescent inpatients diagnosed with either schizophrenia or schizoaffective disorder who were included in the study, 53 (28.2%) were substance users. As shown in Table 1, there were no differences in age, age at first psychiatric admission, or sex distribution between the group of substance users and the nonusers. The groups also did not differ in ethnic origin distribution (data not shown). Cannabis was the most frequently used substance, which was consumed by 44 patients (23.4%).
Discussion
The results support our hypothesis that adolescent inpatients with schizophrenia and schizoaffective disorder who use substances comprise a subgroup with specific clinical characteristics. This is true whether such patients are evaluated from the perspective of a psychotic disorder or from the substance use aspect.
The rate of substance use among the schizophrenic inpatients in our study (28.2%) was in the lower range reported in the literature [1], [2], [3], [4], [5], [6], [7], [8]. This may be
Acknowledgment
This study was supported in part by the Research Foundation for the Prevention of Suicide in Israeli Children and Adolescents, Geha Mental Health Center, Petah Tiqva, Israel.
References (62)
- et al.
Problem drinking in hospitalized schizophrenic patients
Addict Behav
(1980) - et al.
Prevalence and patterns of “dual diagnosis” among psychiatric inpatients
Compr Psychiatry
(1994) - et al.
Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients
Schizophr Res
(1999) - et al.
Testing hypotheses about the relationship between cannabis use and psychosis
Drug Alcohol Depend
(2003) - et al.
Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years
J Am Acad Child Adolesc Psychiatry
(2004) - et al.
Cannabis use and dimensions of psychosis in a nonclinical population of female subjects
Schizophr Res
(2003) - et al.
Patterns of use and psychopathology in chronic marijuana users
Psychiatr Clin North Am
(1986) - et al.
Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity
Psychiatry Res
(2001) - et al.
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol
Schizophr Res
(2004) - et al.
Is the substance abuse of inpatients with schizophrenia overlooked?
Gen Hosp Psychiatry
(2001)
Low prevalence of smoking in patients with autism spectrum disorders
Psychiatry Res
Neurobiology of marijuana abuse
Trends Pharmacol Sci
Gender differences in substance use disorders
Psychiatr Clin North Am
Women and substance abuse
Med Clin North Am
Epidemiology of substance use disorders in women
Obstet Gynecol Clin North Am
Psychiatric comorbidity in hospitalized adolescent substance abusers
J Am Acad Child Adolesc Psychiatry
Schizophrenia and substance abuse
Psychiatr Clin North Am
Drug abuse in schizophrenia
Hosp Community Psychiatry
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study
JAMA
Recent psychostimulant use in hospitalized schizophrenics
J Clin Psychiatry
Drug abuse in schizophrenic patients: clinical correlates and reasons for use
Am J Psychiatry
Substance use diagnoses and discharge patterns among psychiatric inpatients
Hosp Community Psychiatry
Unrecognized cocaine use among schizophrenic patients
Am J Psychiatry
Correlates of patterns of substance abuse among patients with schizophrenia
Hosp Community Psychiatry
Schizophrenia and smoking: an epidemiological survey in a state hospital
Am J Psychiatry
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
Am J Psychiatry
Substance use disorder comorbidity among inpatient youths with psychiatric disorder
Aust N Z J Psychiatry
Homelessness and dual diagnosis
Am Psychol
Alcohol use and abuse in schizophrenia. A prospective community study
J Nerv Ment Dis
Cannabis abuse and the course of recent-onset schizophrenic disorders
Arch Gen Psychiatry
Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports
Schizophr Bull
Cited by (16)
Clinical correlates of cannabis use among adolescent psychiatric inpatients
2012, European PsychiatryCitation Excerpt :The developmental phase of adolescence is regarded as a time of vulnerability to the adverse effects of substance use on neuropsychological functioning [33]. Drugs may interfere with learning, social and personal development and may aggravate preexisting emotional distress [55]. Both emotional problems and conduct disorders have long been recognized to co-occur with substance use disorders [29,28].
Suicidal behavior and related traits among inpatient adolescents with first-episode schizophrenia
2011, Comprehensive PsychiatryCitation Excerpt :According to a recent meta-analysis, 4.9% of these subjects die of suicide, most of them soon after the onset of the illness [2]. Suicidal ideation [3-5], depressive mood disorders [3,6,7], and psychoactive substance abuse/dependence [7-9] are well-established risk factors for suicide in patients with schizophrenia. Aggression has also been suggested as a possible predicting factor for suicide.
A Nationwide Study Comparing Mental Health Professionals’ Willingness to Try Hallucinogenic Drugs in Basic Research or Clinical Practice
2022, Journal of Psychoactive DrugsPrevalence and clinical correlates of substance use disorders in South African Xhosa patients with schizophrenia
2021, Social Psychiatry and Psychiatric EpidemiologyTargeting the endocannabinoid system in borderline personality disorder: Corticolimbic and hypothalamic perspectives
2021, Current NeuropharmacologyThe prevalence and clinical correlates of substance use disorders in patients with psychotic disorders from an upper-middle-income country
2020, South African Journal of Psychiatry